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Background
Fractional anisotropy in the uncinate fasciculus and the cingulum
may be biomarkers for bipolar disorder and may even be dis-
tinctly affected in different subtypes of bipolar disorder, an area
in need of further research.
Aims
This study aims to establish if fractional anisotropy in the
uncinate fasciculus and cingulum shows differences between
healthy controls, patients with bipolar disorder type I (BD-I) and
type II (BD-II), and their unaffected siblings.
Method
Fractional anisotropy measures from the uncinate fasciculus,
cingulum body and parahippocampal cingulum were compared
with tractography methods in 40 healthy controls, 32 patients
with BD-I, 34 patients with BD-II, 17 siblings of patients with BD-I
and 14 siblings of patients with BD-II.
Results
The main effects were found in both the right and left uncinate
fasciculus, with patients with BD-I showing significantly lower
fractional anisotropy than both patients with BD-II and healthy
controls. Participants with BD-II did not differ from healthy con-
trols. Siblings showed similar effects in the left uncinate fascic-
ulus. In a subsequent complementary analysis, we investigated
the association between fractional anisotropy in the uncinate
fasciculus and polygenic risk for bipolar disorder and psychosis
in a large cohort (n = 570) of healthy participants. However, we
found no significant association.
Conclusions
Fractional anisotropy in the uncinate fasciculus differs signifi-
cantly between patients with BD-I and patients with BD-II and
healthy controls. This supports the hypothesis of differences in
the physiological sub-tract between bipolar disorder subtypes.
Similar results were found in unaffected siblings, suggesting the
potential for this biomarker to represent an endophenotype for
BD-I. However, fractional anisotropy in the uncinate fasciculus
seems unrelated to polygenic risk for bipolar disorder or
psychosis.
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Bipolar disorder can be subdivided into bipolar disorder type I (BD-
I) and bipolar disorder type II (BD-II) based on the intensity, dur-
ation or presence of psychotic symptoms during episodes of ‘high’
mood.1 Therefore, BD-II has been regarded as a milder form of
BD-I, with both subtypes sharing the same neurophysiological
underpinnings; however, recent research has shown clear diver-
gences in their clinical presentation and epidemiology2 and their
genetic basis,3 suggestive of a more fundamental difference between
subtypes. Taking both subtypes together, bipolar disorder is highly
heritable and influenced by the additive effect of a large number of
genes.4 Current theoretical models point at inefficient connectivity
between prefrontal brain areas and subcortical structures associated
with emotion and cognition as the basis of the extreme mood
episodes present in bipolar disorder.5–7 This hypothesis finds
support from several studies reporting differences in white matter
microstructure measures between participants with bipolar disorder
and healthy controls, as measured by magnetic resonance imaging
(MRI).8–13 Among white matter tracts studied, the uncinate fascic-
ulus and the cingulum bundle are suggested to be at the core of the
emotion regulation circuitry,12,14 and several studies have reported
reduced fractional anisotropy in both these tracts in participants
with bipolar disorder compared with healthy controls.7,9,15–17 The
few available studies comparing white matter microstructure
between participants with BD-I and BD-II have shown differences
in fractional anisotropy across subtypes.18–20 Our group15 has pre-
viously used tractography to focus on the uncinate fasciculus and
showed reduced fractional anisotropy in participants with BD-I
compared with participants with BD-II and healthy participants,
along with behavioural and blood oxygenation level dependent
(BOLD) responses to an emotion paradigm suggestive of emotion
regulation deficits in participants with BD-I, but not in participants
with BD-II. White matter microstructure in the uncinate fasciculus
was thus posited as a potential biomarker, which could explain
the phenotypic differences between bipolar disorder subtypes.
Unaffected relatives of patients with bipolar disorder also have
reduced fractional anisotropy21 in whole-brain analyses, supporting
the idea of this representing a potential endophenotype for the
disorder.
In this study, we aimed to confirm our previous results of
reduced fractional anisotropy in the uncinate fasciculus of partici-
pants with BD-I compared with participants with BD-II and
healthy controls by using a larger sample, and to extend this com-
parison into the cingulum bundle. We restricted our analyses to
these tracts based on previous literature and the proposed role of
these in emotion regulation because of their anatomical location.
We also explored whether fractional anisotropy reductions in
tracts showing differences between participants with bipolar dis-
order and healthy controls are also present in non-affected siblings
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of participants with bipolar disorder, indicative of a familial aggre-
gation. Finally, we examined whether fractional anisotropy in these
tracts is associated with polygenic risk for bipolar disorder22 and/or
psychosis.23
Method
Participants
The total sample included 137 participants: 66 patients with bipolar
disorder (32 with BD-I and 34 with BD-II), 31 of their unaffected
siblings (17 siblings of participants with BD-I and 14 siblings of par-
ticipants with BD-II) and 40 healthy controls. All patients were
recruited from the National Centre for Mental Health (http://
www.ncmh.info) and the Bipolar Disorder Research Network
(http://bdrn.org). These were well-characterised patients previously
diagnosed by trained researchers using standardised clinical inter-
views. A clinically trained and experienced researcher (X.C.)
further interviewed participants with the Mini-International
Neuropsychiatric Interview (MINI)24 to confirm diagnosis and suit-
ability for inclusion. Unaffected siblings were contacted via
recruited patients, and only one sibling was included from each
family. Healthy controls were recruited from the community via
advertisement. Both healthy controls and siblings were also inter-
viewed with the MINI to verify suitability for inclusion.
Participants were invited if they were aged >35 years to minimise
risk of siblings and healthy controls developing bipolar disorder
or psychosis in the future. All participants passed institutional
MRI safety screening and had no history of neurological disorders
or brain injuries. Participants with bipolar disorder had been euthy-
mic – defined as ‘absence of significant mood episodes or changes in
treatment received’ – for at least 2 months before scanning.
Exclusion criteria for all participants included presence of alcohol/
substance dependence within the past 12 months. To avoid con-
founding diagnosis with other psychotic syndromes (e.g. schizo-
phrenia or schizoaffective), participants with bipolar disorder
were excluded if they reported any positive history of delusions or
hallucinations outside a mood episode. Unaffected siblings were
excluded if they reported any personal history of mood disorder
or psychosis. Healthy controls were excluded if they reported any
personal history of any mental disorders or family history of
bipolar disorder or psychosis in first-degree relatives.
All participants gave written informed consent before inclusion
in the study and completed the Hamilton Depression Rating Scale
(HDRS25), the Young Mania Rating Scale (YMRS26) and the
National Adult Reading Test (NART27) on the day of the scan.
The study was approved by the South East Wales Research Ethics
Committee (REC ref: 08/WSE04/67).
Polygenic risk analysis sample
Based on our results, a secondary analysis of fractional anisotropy in
the uncinate fasciculus was performed looking separately at poly-
genic risk scores (PRSs) for bipolar disorder22 and psychosis23 in
a subgroup of participants (n = 661; mean age 19.7 years; 81%
male) from the Avon Longitudinal Study of Parents and Children
(ALSPAC). ALSPAC is a population-based birth cohort of 14 062
live births – with expected delivery dates between 1 April 1991
and 31 December 1992 – of which 13 988 children were alive at
1 year of age. Data within ALSPAC has been reported extensively,28,29
and the study website contains details of all the data that is available
through a fully searchable data dictionary (http://www.bristol.ac.uk/
alspac/researchers/our-data/). Ethical approval for the study was
obtained from the ALSPAC Ethics and Law Committee and the
local National Health Service research ethics committee.
MRI data acquisition
MRI imaging for both samples (case–control and ALSPAC) was per-
formed on the same GE HDx 3T scanner (GE Healthcare,
Milwaukee WI) at Cardiff University Brain Research Imaging
Centre. A T1-weighted brain scan was acquired for co-registration by
an axial three-dimensional fast spoiled gradient recalled sequence
(repetition time (TR)/echo time (TE)/inversion time (TI) = 8/3/450
ms; flip angle 20°; acquisition matrix 256(anterior–posterior) × 192
(left–right) × 172(superior–inferior), 1 mm isotropic voxels), followed
by a diffusion tensor imaging (DTI) sequence with a twice-refocused
spin-echo echo-planar parallel to the AC-PC plane. Acquisition was
peripherally gated to the cardiac cycle. Data were obtained from 60
slices of 2.4 mm thickness (field of vision 230 mm, matrix size 96 ×
96, TE = 87 ms and parallel imaging (Array coil Spatial Sensitivity
Encoding Technique (ASSET) factor 2), b-values 0 and 1200 s/mm2),
encoding diffusion along 30 isotropically distributed directions and
three non-diffusion-weighted scans according to an optimised gradient
vector scheme.30 Part of the ALSPAC sample (n = 219) was acquired as
60 directions, of which the optimal 30 directions were selected31
together with the first three b-value 0 images, to make this data-set
equivalent to the above and to allow for joint processing of all data.
DTI data processing
DTI data were processed with ExploreDTI version 4.8.3.32 First, T1
structural data were downsampled to 1.5 × 1.5 × 1.5 mm resolution.
Eddy current and participant motion correction were performed with
an affine registration to the non-diffusion-weighted images.33 Echo-
planar imaging correction of the DTI data was performed, warping
the data to the downsampled T1 three-dimensional fast spoiled gradi-
ent recalled sequence.34RESTORE35 andRESDORE36 correctionswere
run, together with free water correction.37 Whole-brain tractography
was performed with a damped Richardson–Lucy algorithm.38
Termination criteria were an angle threshold > 45°, fiber orientation
density function peak < 0.05 and fractional anisotropy < 0.2.
For the case–control sample, fibre tracts were obtained through
an automated tractography pipeline,39 informed by manual tracto-
graphy performed by a researcher (S.F.F.). As our method of seg-
menting the cingulum does not include the majority of the
parahippocampal part of the cingulum bundle (PHC), this was cal-
culated separately. Each automatically reconstructed tract was visu-
ally inspected in ExploreDTI and edited where necessary, to reach
the same quality as manual tractography. During this process, the
researcher (S.F.F.) was kept blind to participant’s group allocation.
For an example of tracts see supplementary Appendix 1 available at
https://doi.org/10.1192/bjp.2018.101. Where it was not possible to
successfully reconstruct a tract, this was excluded. The final
numbers included were left uncinate fasciculus, n = 131; right
uncinate fasciculus, n = 137; right and left cingulum body, n = 137;
left PHC, n = 135 and right PHC, n = 134.
For the ALSPAC PRS group, an automated tractography script
model was used to segment the uncinate fasciculus. After validation
of the automatic tractography model, tracts flagged up because of a
small number of streamlines or low fractional anisotropy values
were manually checked, and deleted when tracts were unsuccess-
fully reconstructed. Final numbers were n = 652 for the left uncinate
fasciculus n = 658 for the right uncinate fasciculus.
In both cases, fractional anisotropy values were extracted for the
tracts of interest, by calculating the average of fractional anisotropy
measures at each vertex of each streamline in the tract.
Statistical analysis
Demographic and clinical variables were compared across groups
by analysis of variance (ANOVA), except for YMRS and HDRS
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scores, for which suitable non-parametric tests (Kruskal–Wallis)
were used. Gender distribution across groups was compared by
χ2 test. Clinical descriptors (not available in all participants) were
compared between participants with BD-I and BD-II by t-tests.
Fractional anisotropy was compared by means of two separated
ANOVAs, one including BD-I, BD-II and healthy controls, and a
second including siblings of participants with BD-I, siblings of
participants with BD-II and healthy controls. In both cases,
Fisher’s least significant difference post hoc testing was applied
where appropriate. Bonferroni correction was used to correct for
multiple comparisons.
Polygenic risk analysis
Quality-controlled genotype data were received from the University
of Bristol. Briefly, a total of 9912 participants from the ALSPAC
study were genotyped with the Illumina HumanHap550 quad
genome-wide single nucleotide polymorphism (SNP) genotyping
platform (Illumina Inc., San Diego, California, USA) by 23andMe,
subcontracting the Wellcome Trust Sanger Institute (Cambridge,
UK) and the Laboratory Corporation of America (Burlington,
North Carolina, USA). Individuals were removed if they had
undetermined X-chromosome heterozygosity; abnormal heterozy-
gosity; cryptic relatedness up to third-degree relatives, using identity
by descent; genotyping completeness < 97%; and non-European
ethnicity admixture detected by a multidimensional scaling analysis
seeded with HapMap2 individuals. Markers with minor allele fre-
quency (MAF) < 0.01, complete genotyping < 95% and an exact
test of Hardy–Weinberg equilibrium (P < 5E−07) were removed.
After quality control, 8365 unrelated individuals and 500 527 geno-
typed SNPs were available for analysis. Autosomal chromosomes
were imputed with the reference panel HRCv1.1 (hrc.r1.1.2016),40
using a mixed population panel. Phasing was done by Eagle v2.341
and imputation was done by Mimimac3.42 Imputed data were
converted to best guess genotypes, using plink 1.943 with multiallelic
sites, and variants with an exact test of Hardy–Weinberg equilib-
rium (P < 1E−06) and MAF < 0.01 were removed.
PRSs were calculated according to the International
Schizophrenia Consortium method.22 Two polygenic scores were
generated: one for bipolar disorder22 and one for bipolar disorder
plus schizophrenia cases versus healthy controls.23 which can be
considered a proxy for psychosis, and can therefore be more pre-
dictive of BD-I than BD-II in our sample.44 Training data for
bipolar disorder were taken from the Cross-Disorder Group of
the Psychiatric Genomics Consortium,45 with 6990 individuals
with bipolar disorder and 4820 controls. For combined bipolar dis-
order and schizophrenia score, data from Ruderfer et al23 on 19 779
individuals (10 410 with bipolar disorder and 9369 with schizophre-
nia) and 19 423 non-overlapping controls were used as training
data. Scores were generated in plink43 (with –score), using six
nested progressive P-value thresholds of 0.00001, 0.0001, 0.01, 0.1,
0.3 and 0.5. SNPs with MAF < 0.1 and imputation quality < 0.9
were removed. Linkage-disequilibrium independent SNPs were
retained by informative pruning in plink43 (–clump to remove
SNPs with linkage disequilibrium > 0.1). A total of 570 individuals
had both PRSs and brain imaging phenotypes available. Linear
regression was performed separately for each PRS threshold and
left and right fractional anisotropy values, using PRS as the explana-
tory variable and adjusting for age and gender as covariates.
Results
Demographics and clinical description
Groups did not differ with regards to age, gender distribution or
performance on the NART (P > 0.1). As expected, both bipolar dis-
order groups showed higher scores in the HDRS and YMRS than the
other groups (both P < 0.01), although scores remained well below
clinical thresholds (Table 1).
On average, participants with bipolar disorder in our study
experienced their first mood episode at age 19 years despite first
being diagnosed with bipolar disorder at age 31 years; those vari-
ables did not differ between BD-I and BD-II groups (t(50) = 0.21,
P > 0.1; and t(54) = 1.24, P > 0.1, respectively). Only nine partici-
pants in our clinical sample (14%) were free of medication at the
time of this study, whereas the majority (n = 36, 65%) were taking
a combination of at least two different class of drugs (see Table 2
for details). One-third of the participants with bipolar disorder
(n = 22; 12 with BD-I, 10 with BD-II) had history of at least one
anxiety-related comorbid diagnosis, with panic disorder with/
without agoraphobia being the most prevalent (31% of participants
with BD-I, 35% of participants with BD-II), followed by obsessive–
compulsive disorder (13% of participants with BD-I, 12% of
participants with BD-II), with health anxiety, eating disorder and
generalised anxiety disorder present at a much lower rate (3% of
the total sample, n = 2). Because of the strict inclusion criteria, no
other diagnoses were present in this sample. Only two siblings
presented with mental health history, referring past history of
generalised anxiety disorder (n = 1) and health anxiety (n = 1).
Following our inclusion criteria, control participants had no
history of any psychiatric disorder.
Fractional anisotropy between-groups analyses
ANOVAs comparing fractional anisotropy across patients and con-
trols showed a significant group effect in left and right uncinate
fasciculus (F(2,97) = 5.87, P = 0.004; F(2,103) = 7.22, P = 0.001;
respectively). These comparisons survived Bonferroni correction.
Post hoc analysis showed that in both cases the effect was driven
by participants with BD-I showing reduced fractional anisotropy
compared with both healthy controls (P = 0.001 for both left and
right) and participants with BD-II (P = 0.019 and P = 0.003, respect-
ively, for left and right). However, there was no difference between
participants with BD-II and healthy controls (P > 0.1) (Fig. 1). To
exclude an effect of age in these results, the analyses were repeated
with age as a covariate, and results remained almost identical.
Table 1 Demographic characteristics and psychometric scores across groups
Healthy controls
n = 40
BD-I
n = 32
BD-II
n = 34
Sib-I
n = 17
Sib-II
n = 14 Group comparison
Females, n (%) 24 (60) 22 (68) 19 (56) 9 (53) 9 (64) χ2 (4) = 1.710, P > 0.1
Age, mean (s.d.) 43.5 (4.9) 45.0 (6.2) 42.8 (7.0) 47.2 (5.5) 43.6 (8.0) F(4,132) = 1.763, P > 0.1
NARTa, mean (s.d.) 36.8 (7.0) 35.2 (8.3) 34.8 (6.9) 36.1 (5.5) 35.4 (7.9) F(4,121) = 0.348, P > 0.1
YMRS, mean (s.d.) 0.45 (0.8) 2.72 (2.4) 2.65 (3.0) 0.53 (0.7) 0.86 (1.1) χ2 (4) = 46.885, P < 0.01
HDRS, mean (s.d.) 0.48 (0.9) 3.50 (3.1) 3.85 (3.7) 1.00 (1.2) 1.57 (1.9) χ2 (4) = 26.854, P < 0.01
BD-I, participants with bipolar disorder type I; BD-II, participants with bipolar disorder type II; HDRS, Hamilton Depression Rating Scale; NART, National Adult Reading Test; Sib-I, unaffected
siblings of participants with bipolar type I; Sib-II, unaffected siblings of participants with bipolar type II; YMRS: Young Mania Rating Scale.
a. Number of correct responses in the NART is reported.
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ANOVAs including fractional anisotropy in cingulum body or
PHC showed no significant group effect (left cingulum body
F(2,103) = 2.53, P = 0.08; right cingulum body F(2,103) = 1.37;
left PHC F(2,101) = 0.011; right PHC F(2,101) = 1.30; all other
P > 0.1). Mean fractional anisotropy and s.d. for all tracts across
groups are presented in supplementary Appendix 2.
Because this study contained a number of participants (BD-I
n = 15, BD-II n = 14 and healthy controls n = 18) included in our
previously reported results,15 we re-ran the tests with only newly
recruited participants. Results mainly replicated those listed
above, with both left and right uncinate fasciculus being signifi-
cantly different between groups, a result which survived
Table 2 Clinical characterisation of participants with BD-I and BD-I
BD-I
n = 32
BD-II
n = 34 Group comparison
Age at first episode, mean (s.d.) 19 (5.8) 19 (7.0) t (50) = 0.21, P > 0.1
Age at diagnosis, mean (s.d.) 30 (6.9) 34 (9.5) t (54) = 1.24, P > 0.1
Co-diagnosis of anxiety disorder, n (%) 12 (38) 10 (29) χ2 (1) = 0.49, P > 0.1
Medication, n (%)a
Non-medicated 1 (3) 8 (24) χ2 (1) = 5.60, P < 0.05
Antidepressants 16 (50) 15 (44) χ2 (1) = 3.65, P > 0.1
Lithium 8 (25) 7 (21) χ2 (1) = 2.49, P > 0.1
Anticonvulsants 16 (50) 15 (44) χ2 (1) = 3.65, P > 0.1
Antipsychotics 20 (63) 7 (21) χ2 (1) = 12.88, P < 0.001
Combination of above 22 (69) 14 (41) χ2 (1) = 5.82, P < 0.05
BD-I, participants with bipolar disorder type I; BD-II, participants with bipolar disorder type II.
a. Medication data from one participant with BD-I was inaccessible.
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Fig. 1 Scatterplot presenting fractional anisotropy values across healthy controls and participants with bipolar disorder type I (BD-I), type II
(BD-II) (top panel), and unaffected siblings of bipolar type I (SIB-I) and type II (SIB-II) participants (bottom panel). Figures on the left correspond to
the left uncinate fasciculus, figures on the right to the right uncinate fasciculus.
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Bonferroni correction. Post hoc testing again showed fractional
anisotropy of participants with BD-I to be less than that of
healthy controls (supplementary Appendix 3).
Based on the results above, we ran ANOVAs for fractional
anisotropy in left and right uncinate fasciculus including
unaffected siblings and healthy controls. Results showed a signifi-
cant group effect in the left uncinate fasciculus (F(2,67) = 3.47,
P = 0.037) but not in the right uncinate fasciculus (F(2,68) = 2.03,
P > 0.1). Post hoc pairwise comparisons showed that the left uncin-
ate fasciculus effect was again driven by siblings of participants with
BD-I showing reduced fractional anisotropy compared with healthy
controls (P = 0.012). However, in this case, no other post hoc
comparison was significant, and the main ANOVA’s group effect
did not survive Bonferroni correction. For completeness, we ran
the ANOVAs for fractional anisotropy in the cingulum body and
PHC, but again, none of these resulted in a significant group
effect: left cingulum body F(2,68) = 0.38; right cingulum body
F(2,68) = 1.35; left PHC F(2,68) = 0.32; right PHC F(2,67) = 1.65;
all P > 0.1.
Finally, post hoc paired sample t-tests comparing participants
with bipolar disorder and their unaffected siblings showed no signifi-
cant difference in the uncinate fasciculus between those with BD-I and
siblings of participants with BD-I (left: t(12) = 0.172, P > 0.1; right:
t(13) = 1.286, P > 0.1) or those with BD-II and siblings of participants
with BD-II (left: t(10) = 0.448, P > 0.01; right: t(10) = 0.784, P > 0.1).
Medication effects on BD-I and BD-II
Point-biserial correlations between each medication class status (i.e.
taking versus not taking) and fractional anisotropy in the uncinate
fasciculus showed a significant positive association between lithium
status and fractional anisotropy in the left uncinate fasciculus (r =
0.37, P = 0.004) and negative association between anticonvulsant
status and right uncinate fasciculus (r =−0.26, P = 0.036). There
were trends between lithium status and fractional anisotropy in
the right uncinate fasciculus (r = 0.24, P = 0.055), and combination
of drugs treatment status and fractional anisotropy in the left uncin-
ate fasciculus (r = 0.24, P = 0.069). No other association approached
significance. Regression analyses were then run to ascertain whether
clinical group allocation (i.e. BD-I versus BD-II) still explained a sig-
nificant amount of variance after accounting for fractional anisot-
ropy variance explained by those medication variables. Clinical
group allocation (BD-I versus BD-II) still explained a significant
amount of fractional anisotropy in the left uncinate fasciculus
after accounting for variance explained by lithium status (R2
change 0.103, F(1,57) = 7.73, P = 0.007), and the same was found
for the right uncinate fasciculus (R2 change 0.124, F(1,62) = 9.42,
P = 0.003). Similarly, clinical group significantly predicted fractional
anisotropy in the right uncinate fasciculus after accounting for vari-
ance associated with anticonvulsant status (R2 change 0.101,
F(1,62) = 7.57, P = 0.008), and in the left uncinate fasciculus after
accounting for variance explained by combined drugs treatment
(R2 change 0.149, F(1,57) = 10.72, P = 0.002).
Association between fractional anisotropy in the
uncinate fasciculus and polygenic risk for bipolar
disorder and psychosis
There was no significant correlation between polygenic risk for
bipolar disorder or psychosis at any of the six P-value thresholds
used and fractional anisotropy in the left or right uncinate fascic-
ulus. In all cases, R2 values remained very low (<0.01; supplemen-
tary Appendix 4).
Discussion
This study contributes to the gradual unravelling of the neuropatho-
physiology of bipolar disorder. Our main aim was to test our hypoth-
esis of reduced fractional anisotropy in the uncinate fasciculus in
patients with BD-I, but not BD-II. We also aimed to extend this
research into the cingulum, where we expected the same pattern of
effects. The results supported the former, but not the latter.
Interestingly, white matter microstructure differences in the uncinate
fasciculus were partially mirrored in unaffected siblings, suggesting
this as a potential endophenotype specifically for BD-I. Despite the
potential genetic basis of this difference suggested by our results in
siblings, we did not find any association between fractional anisot-
ropy in the uncinate fasciculus and polygenic scoring for bipolar
disorder or psychosis in a larger, independent population sample.
Our results confirmed previously reported findings of decreased
fractional anisotropy in the uncinate fasciculus of participants with
bipolar disorder.10,11,19,46We also confirmed previous findings from
our group15 in a larger sample, showing this to be the case for BD-I,
but not BD-II. Rather than showing an intermediate position
between BD-I and healthy controls, fractional anisotropy in the
uncinate fasciculus for BD-II behaved indistinguishably from
healthy controls, but significantly differed from BD-I. This result
indicates a potential distinct pathophysiological mechanism
between bipolar subtypes, rather than supporting the hypothesis
of a simple difference in symptom severity, andmerits further inves-
tigation. Interestingly, previous research has found a similar pattern
of white matter deficits in frontal and parietal regions between
patients with BD-I and schizophrenia.46 In accordance with the diag-
nostic criteria, the patients recruited for this study with a BD-II diag-
nosis did not experience psychosis during episodes of high mood and
in our sample, most people with BD-II also denied experiencing
psychotic symptoms during depression. The majority of our partici-
pants with BD-I did report experiencing psychotic symptoms during
mania. Thus, this difference in fractional anisotropy between bipolar
disorder subtypes in the uncinate fasciculus could reflect vulnerability
to psychosis rather than mood symptoms. Future research should
address this question, looking at fractional anisotropy in the uncinate
fasciculus as a potential crosscutting biomarker for psychosis follow-
ing the research domain criteria perspective.47
Our results did not concur with previous findings in the cingu-
lum indicating reduced fractional anisotropy in bipolar disorder
compared with healthy controls,9,12,19,20 even when combining all
participants with bipolar disorder into a single group (supplemen-
tary Appendix 5). This could be explained by methodological
differences. Most previous findings for the cingulum were based
on voxel-wise comparisons8,19,20 or used a very different tract
mapping methodology9,12 than in this study. To our knowledge,
only two previous studies used equivalent methods of fibre tracking
to this study,10,13 one of which also failed to observe significant
group effects for the cingulum.10 The advantage of tractography
over voxel-wise methods is its power to detect effects in predefined
tracts of interest rather than representing an exploratory approach
across the whole brain, requiring more correction for multiple com-
parisons. Because of our strong a priori hypotheses about the uncin-
ate fasciculus, cingulum body and PHC, tractography was selected
as the most adequate approach. In any case, our results should
call into question the relevance of fractional anisotropy in the
cingulum as a potential biomarker for bipolar disorder.
Interestingly, our results are also suggestive of reduced frac-
tional anisotropy in the left uncinate fasciculus for siblings of
participants with BD-I compared with healthy controls, but not
for siblings of participants with BD-II. No significant group effect
was found in the right uncinate fasciculus despite post hoc testing
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showing a trend toward lower fractional anisotropy, again between
siblings of participants with BD-I and healthy controls (P = 0.08).
We also found that both sibling groups did not differ from their
affected relatives with regards to fractional anisotropy in the uncin-
ate fasciculus. These findings are consistent with previous research
reporting siblings of patients with bipolar disorder showing inter-
mediate fractional anisotropy values between patients and controls
in various white matter regions,48 and therefore placing fractional
anisotropy in the uncinate fasciculus as a potential endophenotype
for this disorder. This is the first time that this result incorporating
patients and their siblings has been reported based on tractography
on a priori selected tracts of interest rather than on a whole-brain
voxel-wise exploratory approach. Importantly, our sibling groups
were selected on the basis of an absence of any personal history of
mood disorders and psychosis, and their age (>35 years), which
indicates lower probability of developing bipolar disorder in the
future;49 as a consequence, our sibling groups can be considered
at a higher familial risk but yet resilient. This strengthens the
hypothesis of lower fractional anisotropy in the uncinate fasciculus
representing an endophenotype for BD-I, likely to be present as a
premorbid risk marker independent of mental state and psycho-
pathological history, and endorses future research in this area.
Considering the results discussed so far and previous literature
showing fractional anisotropy to be heritable,50 one could have
predicted that common genetic variance associated with bipolar
disorder or psychosis would correlate with fractional anisotropy in
the uncinate fasciculus, which surprisingly was not the case.
Among currently available genome-wide association studies for
bipolar disorder, BD-I is over-represented compared with BD-II,51
and therefore we predicted that any bipolar disorder polygenic
score based on this data would mainly represent BD-I risk. Also,
as we advocated earlier, if fractional anisotropy in the uncinate
fasciculus reflects vulnerability for psychosis rather than mood
disorder, one would expect the polygenic score for psychosis23 to
also correlate with fractional anisotropy in the uncinate fasciculus.
However, our results did not confirm this notion, calling into ques-
tion whether the familial effects reported above are driven by
common genetic factors. Further replication in larger samples and
with more suited polygenic scores than the ones currently available
(i.e. specific for BD- I or BD-II) would be required before any firm
conclusions can be drawn.
Our study has some limitations that should be noted. First our
bipolar disorder groups include participants used in a previous
study reporting fractional anisotropy differences in uncinate fascic-
ulus.15 It is important to notice, however, that these two samples
were acquired in the same MRI machine and with exactly the
same acquisition sequence, and all data were (re)processed together
for this study. We also replicated our analyses after excluding those
participants who took part in the previous study, and obtained very
similar results, albeit with decreased statistical power (supplemen-
tary Appendix 3). Second, because of our stringent inclusion criteria
(i.e. lack of any history of mood disorder or psychosis, age >35 years
and only one sibling per family), our sample size for unaffected sib-
lings is modest, which has limited our power to detect significant
effects. Despite the limitation in sample size, the use of such a
group of siblings strengthens our conclusion regarding fractional
anisotropy in the uncinate fasciculus as a potential endophenotype
for BD-I. Finally, the potential confounding effect of medication is a
common problem in studies recruiting patients with chronic ill-
nesses like bipolar disorder. Despite this, we have shown that differ-
ences in fractional anisotropy in the uncinate fasciculus found
between participants with BD-I and BD-II were not fully explained
by medication status. Moreover, it has been suggested that medica-
tion effects are smaller than originally thought but could increase
type II errors because of the normalisation effect over brain function
and structure.52 With this in mind, we believe that our main results
regarding differences between patients and controls are not second-
ary to medication.
In conclusion, we showed the microstructure of white matter in
the uncinate fasciculus to be compromised in individuals with BD-I
but not in individuals with BD-II, compared with healthy controls.
A similar effect, albeit reduced, was seen in unaffected siblings of
participants with BD-I, indicating familiality and postulating
fractional anisotropy in the uncinate fasciculus as a potential
endophenotype for bipolar disorder.
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